Connection

Besim Ogretmen to Neoplasms

This is a "connection" page, showing publications Besim Ogretmen has written about Neoplasms.
Connection Strength

1.371
  1. Mechanisms of Ceramide-Dependent Cancer Cell Death. Adv Cancer Res. 2018; 140:1-25.
    View in: PubMed
    Score: 0.272
  2. Sphingolipid metabolism in cancer signalling and therapy. Nat Rev Cancer. 2018 Jan; 18(1):33-50.
    View in: PubMed
    Score: 0.270
  3. Ceramide induced mitophagy and tumor suppression. Biochim Biophys Acta. 2015 Oct; 1853(10 Pt B):2834-45.
    View in: PubMed
    Score: 0.222
  4. Concerted functions of HDAC1 and microRNA-574-5p repress alternatively spliced ceramide synthase 1 expression in human cancer cells. EMBO Mol Med. 2012 Feb; 4(2):78-92.
    View in: PubMed
    Score: 0.179
  5. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004 Aug; 4(8):604-16.
    View in: PubMed
    Score: 0.108
  6. Depletion of COPI in cancer cells: the role of reactive oxygen species in the induction of lipid accumulation, noncanonical lipophagy and apoptosis. Mol Biol Cell. 2022 12 01; 33(14):ar135.
    View in: PubMed
    Score: 0.095
  7. Polyploid giant cancer cells are dependent on cholesterol for progeny formation through amitotic division. Sci Rep. 2022 05 27; 12(1):8971.
    View in: PubMed
    Score: 0.092
  8. CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response. Cell Metab. 2018 01 09; 27(1):85-100.e8.
    View in: PubMed
    Score: 0.067
  9. A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors. Clin Cancer Res. 2017 Aug 15; 23(16):4642-4650.
    View in: PubMed
    Score: 0.065
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.